OncologyTube Professional - Patients Click Here
321,719 video views
Loading........
Description: Brian I. Rini, MD, Cleveland Clinic discusses VEGF + I/O combinations in Renal Cell Carcinoma at the 13th European International Kidney Cancer Symposium 2018 in Prague.
10:51
Alison Fielding, MD, presents A Patient View at the International Kidney Cancer Symposium 2018
by:kidneycancer | 211 views
13:46
Lisa M Pickering, MD, presents Centralisation of RCC Management: What is the volume needed to improve? The Oncologist’s View: Is there an argument for centralisation? at the International Kidney Cancer Symposium 2018
by:kidneycancer | 176 views
12:31
Mr. Rajesh Nair FRCS (Urol.), FEBU, MSc., presents Centralisation of Renal Cell Carcinoma Management: What is the Volume Needed to Improve? The Surgeon’s Point of View at the International Kidney Cancer Symposium 2018
by:kidneycancer | 184 views
09:55
Guillermo de Velasco MD, PhD, presents Treatment after Immune checkpoint inhibition: Impact on biology? at the International Kidney Cancer Symposium 2018.
by:kidneycancer | 192 views
15:21
Laurence Albiges, MD, PhD, presents Treatment after immune checkpoint in first/second line setting: Clinical perspective at the International Kidney Cancer Symposium 2018
by:kidneycancer | 238 views
10:54
Ravi Barod PhD FRCS (Urol) presents Minimally invasive partial nephrectomy is NOT a cause of seeding of RCC at the International Kidney Cancer Symposium.
by:kidneycancer | 114 views
62:59
Christopher G. Wood, M.D., F.A.C.S. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX chairs an esteem panel to discuss challenging renal cases at the International Kidney Cancer symposium 2018. Viktor Grunwald, Camillo Porta, Seva Matveev, Karim Bensalah
by:kidneycancer | 63 views
15:39
Paul Russo, MD, FACS, presents DEBATE: Cancer Seeding and Minimally Invasive Kidney Tumor Surgery at the International Kidney Cancer Symposium 2018
by:kidneycancer | 41 views
17:10
Sumanta Kumar Pal, M.D. Associate Professor, Department of Medical Oncology & Therapeutics Research Co-Director, Kidney Cancer Program City of Hope Comprehensive Cancer Center discusses the New Generation of Biomarkers for IO: Fact or Fiction? at the 13th European International Kidney Cancer Symposium 2018 in Prague.
by:kidneycancer | 168 views
10:55
Bernard Escudier, Gustave Roussy, Villejuif, France asks teh question "Combination Trials with New IO Agents: How Can we Define the Best Treatment with Current Data?" at the 13th European International Kidney Cancer Symposium 2018 in Prague.
by:kidneycancer | 58 views

About kidneycancer
Description: The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries. We fund, promote, and collaborate with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. We educate families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.

Company: KCA was founded in 1990 by a small group of patients, including Eugene P. Schonfeld, Ph.D., and medical doctors in Chicago, Illinois. It is a nonprofit charity incorporated in the State of Illinois. I
Links
Channel Url:

Website:


Social Links: